儿童进行性肺动脉高压优化治疗后干预策略:ATS临床实践指南
美国胸科学会发布儿童进行性肺动脉高压优化治疗后管理指南,多学科专家组基于系统综述和GRADE方法制定推荐。指南针对干预策略给出推荐或反对意见,指出该领域 empirical evidence 显著缺乏,推荐主要依据有限证据结合专家意见,并明确未来研究方向。
要点
- 针对优化治疗后仍进展的儿童肺动脉高压,指南给出干预策略的推荐或反对意见。
- 证据基础显著缺乏,推荐结合有限实证证据与专家意见制定。
- 明确未来研究重点领域以填补儿童进行性肺动脉高压管理证据缺口。
核心结论
- 尽管儿童肺动脉高压人群增长,优化药物治疗后仍进展者的管理实证证据显著缺乏。
- 专家组基于有限实证证据结合专家意见,对干预策略制定推荐或反对意见及理由。
研究设计与样本
- 美国胸科学会官方临床实践指南,由多学科专家组制定。
- 专家组识别优化治疗后仍进展的儿童肺动脉高压管理相关问题,进行系统文献综述,并应用GRADE方法制定临床推荐。
主要发现
- 专家组评估各拟议问题中干预措施的利弊平衡,并考虑主要结局价值及资源、公平性、可接受性和可行性。
- 针对优化治疗后仍进展的儿童肺动脉高压,制定推荐或反对特定干预策略的意见。
临床怎么用
- 临床医生可参考本指南对优化治疗后仍进展的儿童肺动脉高压患者进行干预策略决策。
- 推荐基于有限实证证据与专家意见,需结合患儿具体情况谨慎应用。
局限性
- 关于优化药物治疗后仍进展的儿童肺动脉高压管理,实证证据显著缺乏。
- 推荐主要基于有限实证证据结合专家意见制定。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Pulmonary hypertension in children is progressive with wide variability in prognosis. This document provides an evidence-based clinical practice guideline for the management of children with progressive pulmonary hypertension despite optimal therapy. Methods: A multidisciplinary panel identified pertinent questions regarding the management of children with pulmonary hypertension that has progressed despite optimal therapy, conducted systematic reviews of the relevant literature, and applied the Grading of Recommendations, Assessment, Development and Evaluation approach to develop clinical recommendations. Results: After reviewing the research evidence, the panel considered the balance of desirable (benefits) and undesirable (harms and burdens) effects of the interventions in each proposed question. Valuation of our main outcomes was also considered, together with resources required, equity, acceptability, and feasibility. Recommendations were developed for or against interventional strategies specific to children with pulmonary hypertension that has progressed despite optimal therapy. Conclusions: Although there is a growing population of children with pulmonary hypertension, there is a striking lack of empirical evidence regarding management of those whose disease has progressed despite optimal pharmacotherapy. The panel formulated and provided the rationale for clinical recommendations for or against interventional strategies on the basis of this limited empirical evidence, coupled with expert opinion, to aid clinicians in the management of these complex pediatric patients. In addition, we identified important areas for future research.
引用
- Hayes D, Jennerich AL, Coleman RD, et al. Interventional Strategies for Children with Progressive Pulmonary Hypertension Despite Optimal Therapy: An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2025. PMID: 39531626. doi:10.1164/rccm.202410-1901ST
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。